Results 201 to 210 of about 243,182 (378)

Disseminated cryptococcosis involving the adrenal gland and brain in an immunocompetent patient: A case report. [PDF]

Medicine (Baltimore)
Rao Q, Wu F, Su D, Song X, Su J, Ma L, Xu J, Fan S, Zhu J, Wen J.   +9 more
europepmc   +1 more source

Mapping Of Adrenal Gland Diseases Research In Middle East Countries: A Scientometric Analysis, 2007-2013

, 2016
Zahra Emami, Mohammad E. Khamseh, Nahid Hashemi‐Madani, Iman Kermani   +3 more
openalex   +1 more source

Non‐canonical PKG1 regulation in cardiovascular health and disease

British Journal of Pharmacology, EarlyView.
It is well established that the cyclic GMP‐dependent protein kinase I (PKG1) is canonically activated by cyclic guanosine monophosphate (cGMP), enabling its regulation of vascular tone, cardiac function and smooth muscle homeostasis. However, diverse non‐canonical stimuli of PKG1 have also been identified.
Jie Su, Joseph Robert Burgoyne
wiley   +1 more source

Adrenal crisis occurring after the application of immune checkpoint inhibitors in a hepatitis B - related hepatocellular carcinoma patient: case report and literature review. [PDF]

Front Immunol
Guo Y, Zhu Q, Ren W, Li F.
europepmc   +1 more source

A combined case with dichotomous ramificated right renal arterial disease and bilateral ganglioneuromatosis presenting catecholamine excess secretion and blood pressure crisis after extraction of ganglioneuroma in right adrenal gland vicinity.

, 1996
小島 元子, 奥野 よしえ, 横山 純   +2 more
openalex   +2 more sources

Addison's disease caused by Paracoccidioides brasiliensis: diagnosis by needle aspiration biopsy of the adrenal gland. [PDF]

, 1996
S. Faiçal, Mila Borri, O.M. Hauache, Sérgio Ajzen   +3 more
openalex   +1 more source

An intracellular recombinant single‐chain variable antibody fragment as a new class of phosphodiesterase type 5 inhibitors

British Journal of Pharmacology, EarlyView.
Background and Purpose Cyclic guanosine monophosphate (cGMP) is a ubiquitous second messenger involved in human (patho‐)physiology. Phosphodiesterase 5 (PDE5) is a major cGMP hydrolyzing enzyme in many cell types including vascular smooth muscle cells (VSMCs). Several highly selective PDE5 inhibitors are in clinical use. However, there are currently no
Kürsat Kirkgöz, Sophie Sprenger, Olga Schweigert, Sanika Mohagaonkar, Matti Walsdorff, Tanja Zeller, Filip Berisha, Viacheslav O. Nikolaev, Sergei D. Rybalkin   +8 more
wiley   +1 more source

Case Report: Adrenal tuberculosis causing primary adrenal insufficiency: diagnosis by ultrasound-guided biopsy. [PDF]

Front Med (Lausanne)
Xiong T, Wang R, Zhou J, Yu B.
europepmc   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

Effect of adrenocorticotropin or adenosin-3',5'-monophosphate on in vitro adrenal synthesis [PDF]

, 1964
Scriba, Peter Christian
core   +1 more source